Literature DB >> 1661690

Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice.

H S Baek1, J W Yoon.   

Abstract

A single administration of complete Freund's adjuvant (CFA), type 1 carrageenan (Car), or silica 7, 2, and 2 days, respectively, before infection with a low dose (1 x 10(2) plaque-forming units/mouse) of encephalomyocarditis D (EMC-D) virus resulted in a significant increase in the incidence of diabetes in SJL/J mice (100%) compared with untreated EMC-D virus-infected mice (40%). Peritoneal macrophages were isolated from uninfected SJL/J mice, which had been treated once with silica, and transferred into SJL/J mice 2 days before low-dose EMC-D infection. Approximately 90% of the mice became diabetic, whereas 30% of mice that received virus alone became diabetic. The depletion of macrophages by treatment with the combined anti-Mac-1 and anti-Mac-2 monoclonal antibodies after a single administration of CFA, Car, or silica resulted in almost complete prevention of beta-cell destruction in EMC-D virus-infected mice. Furthermore, none of the mice in which macrophages were depleted by long-term treatment with silica and 10% of the mice treated with Car before virus infection became diabetic. On the basis of these observations, we conclude that macrophages are directly involved in the destruction of beta-cells, leading to the development of clinical diabetes in EMC-D virus-infected mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661690     DOI: 10.2337/diab.40.12.1586

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  Distribution of viral RNA in the spinal cord of DBA/2 mice developing biphasic paralysis following infection with the D variant of encephalomyocarditis virus (EMC-D).

Authors:  M Takeda; R Miura; K Shiota; K Hirasawa; M J Lee; S I Itagaki; K Doi
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

Review 3.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.

Authors:  A L Scarim; M Arnush; L A Blair; J Concepcion; M R Heitmeier; D Scheuner; R J Kaufman; J Ryerse; R M Buller; J A Corbett
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 5.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

Review 6.  TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

Authors:  Melissa Swiecki; Stephen A McCartney; Yaming Wang; Marco Colonna
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 7.  dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.

Authors:  Yaming Wang; Melissa Swiecki; Stephen A McCartney; Marco Colonna
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

8.  Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  K S Choi; H S Jun; H N Kim; H J Park; Y W Eom; H L Noh; H Kwon; H M Kim; J W Yoon
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients.

Authors:  K Josefsen; H Nielsen; S Lorentzen; P Damsbo; K Buschard
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

10.  Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  Young-Sun Lee; Na Li; Seungjin Shin; Hee-Sook Jun
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.